Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1CNS 1

Conditions

Melanoma 23Carcinoma, Non-Small-Cell Lung 10Colorectal Neoplasms 7Neoplasms 5Neoplasm Metastasis 5Skin Neoplasms 4Lung Neoplasms 4Pancreatic Neoplasms 3Uveal Melanoma 2Triple Negative Breast Neoplasms 2Skin Diseases 2Hereditary Sensory and Autonomic Neuropathies 2Brain Neoplasms 2Thyroid Neoplasms 1Thyroid Diseases 1Spinocerebellar Degenerations 1Solid Tumors Harboring a BRAF V600 Mutation 1Solid Tumors 1Solid Tumor 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Noonan Syndrome 5 1Neurofibromatosis 1 1Low-grade Serous Ovarian Cancer 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Glioma 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1

Interventions

XENP 1595 2Cancer Vaccines 2Adjuvants, Immunologic 2veliparib 1glutathione pegylated liposomal doxorubicin 1elacestrant 1binimetinib 1abemaciclib 1Trastuzumab 1Radiosurgery 1RAD1901 1PF-07284890 1Midazolam 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Brain Diseases × binimetinib × Clear all
NCT04543188 2025-10-23

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Pfizer

Phase 1 Terminated
65 enrolled 52 charts
CNSDermatologicThoracic

Brain Diseases, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡